Mesothelioma is divided into four stages based on how far the cancer has spread. Staging applies most formally to pleural mesothelioma (using the TNM system), and it is a key factor in determining treatment options and prognosis. Earlier stages generally allow for more aggressive, potentially life-extending treatment.
How Mesothelioma Is Staged
Staging is not a single test. It is assembled from several, and the order matters because each step can change the answer:
- Imaging — a CT scan of the chest and abdomen is usually first, often followed by PET-CT to look for spread beyond the chest and MRI to judge whether the tumour has invaded the diaphragm or chest wall.
- Tissue diagnosis — staging cannot be settled without pathology. A biopsy confirms mesothelioma and, critically, identifies the cell type, which carries as much weight as the stage number.
- Surgical staging — thoracoscopy for pleural disease, or laparoscopy for peritoneal, lets a surgeon see and sample directly. It is the most accurate step and frequently revises what the scans suggested.
- Lymph node assessment — mediastinoscopy or endobronchial ultrasound samples nodes, because nodal involvement moves a patient between stages and can change whether surgery is offered at all.
Clinical staging versus pathological staging
This distinction causes a lot of confusion and is worth understanding before it happens to you.
Clinical stage is the estimate made before surgery, from imaging and biopsy. Pathological stage is determined afterwards, when a pathologist examines what was actually removed. The two frequently disagree, and the pathological stage is usually the higher of the two — tumour spread tends to be more extensive in person than on a scan.
Being “re-staged” after surgery does not mean the cancer grew during treatment, and it does not mean anyone made a mistake. It means the picture got more accurate. Ask which stage is being quoted when a number is given.
The TNM System
Pleural mesothelioma is staged with TNM, which scores three things separately and then combines them into stages I through IV:
- T (tumour) — how far the primary tumour has grown. T1 is confined to the lining on one side; T4 has invaded structures such as the chest wall, spine, heart or the diaphragm through to the abdomen.
- N (nodes) — whether lymph nodes are involved and which ones. Nodes on the same side as the tumour weigh differently from nodes on the opposite side.
- M (metastasis) — whether the disease has reached distant organs. Any M1 finding is stage IV regardless of T and N.
Because the three are scored independently, two patients at the same stage can have quite different disease. A large tumour with no nodal involvement and a smaller tumour with extensive nodes can land in the same stage and behave differently.
The Four Stages
Stage 1
The cancer is localized — confined to the lining on one side of the chest, with no or minimal spread. The most treatable stage. Patients at stage 1 are the best candidates for aggressive treatment, including surgery, and generally have the most favorable prognosis.
Stage 2
The cancer has begun to spread beyond its origin — potentially into the lung or diaphragm, and possibly to nearby lymph nodes. Surgery combined with chemotherapy and radiation may still be options for eligible patients.
Stage 3
The cancer has spread more extensively into nearby structures — the chest wall, diaphragm, or multiple lymph nodes. Some stage 3 patients may still be surgical candidates, but treatment more often centers on chemotherapy, radiation, and immunotherapy, sometimes in combination.
Stage 4
The most advanced stage — the cancer has spread to distant parts of the body or extensively through the chest. Surgery is generally not an option. Treatment focuses on controlling the disease and relieving symptoms through chemotherapy, immunotherapy, radiation for symptom relief, and palliative care to maximize comfort and quality of life. Clinical trials can also offer access to emerging therapies.
Peritoneal Mesothelioma Is Staged Differently
Mesothelioma of the abdominal lining is not usefully described by the pleural TNM stages, and quoting a “stage 3” or “stage 4” for it can be actively misleading.
Surgeons instead use the Peritoneal Cancer Index (PCI), which divides the abdomen into thirteen regions, scores the tumour bulk in each from 0 to 3, and sums them to a maximum of 39. The score predicts whether cytoreductive surgery with heated intraperitoneal chemotherapy (HIPEC) is feasible and how complete the removal is likely to be.
This matters because peritoneal disease treated with CRS/HIPEC has produced the longest survival reported in any mesothelioma group — outcomes measured in years rather than months for carefully selected patients. A peritoneal diagnosis should be assessed by a surgeon who performs this procedure regularly, and a pleural staging number should not be used to set expectations for it.
What Stage Does Not Tell You
Stage is the largest single factor in prognosis, and it is still only one of several:
- Cell type. Epithelioid disease responds better and is associated with longer survival than sarcomatoid; biphasic falls between the two and tends to track the proportion of epithelioid cells.
- Resectability. Whether a tumour can be removed, and whether lung function and overall fitness can tolerate major surgery, separates the group with the longest reported survival from the group treated with systemic therapy alone.
- Performance status. How well someone is functioning day to day at diagnosis is consistently among the strongest predictors in the published literature.
- Where treatment happens. Mesothelioma is rare enough that most oncologists see very few cases, and multimodal treatment is largely concentrated at centres with dedicated programmes.
Questions Worth Asking About a Stage
- Is this the clinical stage or the pathological stage?
- What are the separate T, N and M scores, not just the combined number?
- Has the cell type been confirmed, and by which immunohistochemical markers?
- Does this stage make surgery possible, and if not, is that because of the tumour or because of fitness?
- Would a second opinion at a mesothelioma centre change the staging or the options?
Staging and Prognosis
Stage strongly influences prognosis, but it is not the only factor — cell type, overall health, and treatment response all matter. Peritoneal mesothelioma is staged differently and, with cytoreductive surgery plus HIPEC, can have outcomes that differ from what stage alone would suggest. See the life expectancy and prognosis guide.
If you or a loved one was diagnosed with mesothelioma at any stage and were exposed to asbestos at work, in the military, or in a building, you may have a legal claim — and acting promptly preserves the most options.
This information is educational, drawn from sources such as the American Cancer Society and National Cancer Institute, and is not medical advice. Consult your own physician about staging and treatment.